These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34818661)

  • 1. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease.
    Karki NR; Arfa AS; Savage N; Kutlar A
    Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five biopsies, one diagnosis: challenges in idiopathic multicentric Castleman disease.
    Semenchuk J; Merchant A; Sakhdari A; Kukreti V
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33229481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
    Lurain K; Yarchoan R; Uldrick TS
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Bertinchamp R; Terriou L
    Rev Med Interne; 2022 Dec; 43(10S1):10S4-10S9. PubMed ID: 36657941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.
    Smedile A; Capuano F; Fraticelli S; Lucioni M; La Fianza A
    J Radiol Case Rep; 2019 Mar; 13(3):28-36. PubMed ID: 31565175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab.
    Plano F; Mancuso S; Camarda GM; Butera MG; Sucato G; Alecci G; Florena AM; Perrone S; Siragusa SM
    Chemotherapy; 2024; 69(1):35-39. PubMed ID: 37634492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castleman disease: a rare case in a young woman.
    Paparella MT; Popolizio T; Grasso D; Serricchio EA; Guglielmi G
    Acta Biomed; 2023 Mar; 94(S1):e2023058. PubMed ID: 36883699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Castleman disease and TAFRO syndrome.
    Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
    Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentric Castlemans disease. Symptoms, diagnostics and therapy.
    Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Sandecká V; Krejčí M; Štork M; Ševčíková S; Král Z
    Vnitr Lek; 2022; 68(1):41-53. PubMed ID: 35459346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal Castleman disease in pediatrics: case report.
    Baserga M; Rosin M; Schoen M; Young G
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):666-9. PubMed ID: 16344673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
    Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.
    Belyaeva E; Rubenstein A; Pierson SK; Dalldorf D; Frank D; Lim MS; Fajgenbaum DC
    Hematol Oncol; 2022 Apr; 40(2):191-201. PubMed ID: 35104370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
    Lang E; Sande B; Brodkin S; van Rhee F
    Ther Adv Hematol; 2022; 13():20406207221082552. PubMed ID: 35251585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Multicentric Castleman Disease with Cutaneous Manifestation: Case Report.
    Kosmidis CS; Mystakidou CM; Koimtzis G; Papadopoulou E; Theodorou V; Katsios NI; Georgakoudi E; Sevva C; Charalampous I; Varsamis N; Koulouris C; Michael C; Papadopoulos K; Anthimidis G; Baka S
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomeruloid hemangioma associated with TAFRO syndrome.
    Shinozaki-Ushiku A; Higashihara T; Ikemura M; Sato J; Nangaku M; Ushiku T; Fukayama M
    Hum Pathol; 2018 Dec; 82():172-176. PubMed ID: 29702119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease.
    Horna P; King RL; Jevremovic D; Fajgenbaum DC; Dispenzieri A
    Haematologica; 2023 Jan; 108(1):207-218. PubMed ID: 35484648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
    Pan Y; Cui Z; Wang S; Zheng D; Deng Z; Tian X; Guo H; Bao W; Zhou S; Wang Y
    BMC Nephrol; 2020 Dec; 21(1):528. PubMed ID: 33276741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease.
    Chrysochoou S; Kreft A; Schneider E
    Case Rep Hematol; 2022; 2022():1840589. PubMed ID: 35399163
    [No Abstract]   [Full Text] [Related]  

  • 19. Castleman disease of the neck: A case report.
    Pasha H; Siddiqui MI; Wasif M
    J Pak Med Assoc; 2020 Feb; 70(2):354-356. PubMed ID: 32063646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric Castleman disease presenting as a chylous pleural effusion.
    Epstein D; Zohar Y; Ovadya D; Ammouri H; Kremer R; Lavi N; Tzoran I; Andrawas ER; Klein E; Miller A
    Pathol Res Pract; 2020 Nov; 216(11):153209. PubMed ID: 32950896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.